Startups

Cx Precision Medicine is developing accessible, blood-based diagnostic and triage tests combining proteomics and machine learning algorithms for neurodegenerative disorders. Founded on patented biomarker technology from Dr. Sid O'Bryant’s laboratory at the University of North Texas Health Science Center at Fort Worth, the company's platform—including its flagship NeuroFirst™ Memory test—empowers primary care clinicians to rule out cognitive impairment early and accelerate targeted specialist care.

CiRC Biosciences is a regenerative medicines company developing cell therapies that restore function in patients affected by degenerative diseases, with an initial focus on neurology and ophthalmology. The platform uses small molecules and growth factors to convert ordinary skin cells into other functional cell types, bypassing the risks of stem cells. CiRC was co-founded by Paragon Biosciences and Dr. Sai Chavala, based on proprietary cellular reprogramming technology developed at the University of North Texas Health Science Center at Fort Worth.

Eyegenex is a biotechnology company developing first-in-class neuroprotective gene and peptide therapies designed to prevent vision loss in chronic optic neuropathies. Leveraging research that was developed and validated in a joint collaboration between the University of North Texas Health Science Center at Fort Worth and the University of Colorado Anschutz Campus, the company targets retinal ganglion cell preservation to halt disease progression in conditions such as glaucoma and normal tension glaucoma (NTG) that do not adequately respond to conventional intraocular pressure-lowering treatments.

 

T2YourHealth is a preventive health technology company – advancing diabetes prevention through innovative strategies and tools. This startup was founded on the patented magnetic resonance T2 relaxation technologies discovered by David P. Cistola, M.D., Ph.D. and his research team while at the University of North Texas Health Science at Fort Worth. The company's platforms identify and manage early metabolic imbalance (EMI), a hidden overlooked condition not detected by conventional medical testing. With early detection and intervention, individuals can avoid prediabetes, type 2 diabetes, and other chronic diseases, while improving health, performance, and quality of life.